Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50,868,756
-
Total 13F shares
-
43,782,930
-
Share change
-
+1,149,756
-
Total reported value
-
$512,285,979
-
Put/Call ratio
-
103%
-
Price per share
-
$11.70
-
Number of holders
-
180
-
Value change
-
+$5,420,902
-
Number of buys
-
97
-
Number of sells
-
76
Institutional Holders of REGENXBIO Inc. - Common Stock (RGNX) as of Q2 2024
As of 30 Jun 2024,
REGENXBIO Inc. - Common Stock (RGNX) was held by
180 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,782,930 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Redmile Group, LLC, JPMORGAN CHASE & CO, STATE STREET CORP, Avidity Partners Management LP, MORGAN STANLEY, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, and Integral Health Asset Management, LLC.
This page lists
180
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.